Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2002-8-21
pubmed:abstractText
The herpes simplex virus thymidine kinase (HSV-tk) gene conferring ganciclovir (GCV)-specific sensitivity to transduced cells might control Graft-versus-Leukemia (GvL)/Graft-versus-Host Disease (GvHD). Human T lymphocytes were engineered with an LSN-tk retroviral vector encoding tk and neomycin resistance (NeoR) genes. A total of 80 x 10(6) tk(+) lymphocytes were injected intraperitoneally in NOD-SCID mice. Engraftment was evaluated by human CD45(+)/CD3(+) cytofluorimetric analysis and NeoR-based polymerase chain reaction (PCR) on peripheral blood, bone marrow, liver, thymus, and spleen on day +5. After 14 days, GCV (10 mg/kg daily) cytofluorimetric analysis and PCR were repeated (day +19). Immunohistological studies with anti-CD3 monoclonal antibody followed by alkaline phosphatase and monoclonal anti-alkaline phosphatase staining were performed on spleen and liver at the same time points. Human CD45(+)/CD3(+) cells were engrafted in all tissues on day +5 according to cytofluorimetry, immunohistology, and PCR. Lymphocytes "homed" to the white pulp T-cell area and to the red pulp; liver localization is prevalently at the periportal area. After GCV (day +19), cytofluorimetry and immunohistology showed very few CD3(+) cells. PCR identified the transgene in 22% tissue samples (positive only in thymus and spleen). GvHD did not occur in any animal. These data demonstrate elevated doses of human-transduced CD3(+) cells engraft in NOD/SCID mice; after GCV, very few CD3(+) cells can be detected and those that escape treatment can be found in the thymus and in the spleen on day +19. Lack of full response to GCV may account for cases of GvHD in patients receiving tk-transduced T lymphocytes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0929-1903
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
756-61
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12189525-Animals, pubmed-meshheading:12189525-Antigens, CD, pubmed-meshheading:12189525-Antiviral Agents, pubmed-meshheading:12189525-Bone Marrow, pubmed-meshheading:12189525-Cell Survival, pubmed-meshheading:12189525-Cells, Cultured, pubmed-meshheading:12189525-Flow Cytometry, pubmed-meshheading:12189525-Ganciclovir, pubmed-meshheading:12189525-Genetic Vectors, pubmed-meshheading:12189525-Herpesviridae, pubmed-meshheading:12189525-Humans, pubmed-meshheading:12189525-Immunoenzyme Techniques, pubmed-meshheading:12189525-Liver, pubmed-meshheading:12189525-Lymphocyte Activation, pubmed-meshheading:12189525-Lymphocyte Depletion, pubmed-meshheading:12189525-Mice, pubmed-meshheading:12189525-Mice, Inbred NOD, pubmed-meshheading:12189525-Mice, SCID, pubmed-meshheading:12189525-Moloney murine leukemia virus, pubmed-meshheading:12189525-Polymerase Chain Reaction, pubmed-meshheading:12189525-Spleen, pubmed-meshheading:12189525-T-Lymphocytes, pubmed-meshheading:12189525-Thymidine Kinase, pubmed-meshheading:12189525-Thymus Gland, pubmed-meshheading:12189525-Transduction, Genetic
pubmed:year
2002
pubmed:articleTitle
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice.
pubmed:affiliation
Hematology and Clinical Immunology Section, Department of Clinical and Experimental Medicine, Perugia University, Perugia, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't